Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
Indian J Med Sci ; 2010 Nov; 64(11) 493-499
Article in English | IMSEAR | ID: sea-145571

ABSTRACT

Objective : In the few cases of childhood dirrhea that require the antimicrobial therapy, the correct choice of the drug depends on detailed previous knowledge of local strains and pattern of antimicrobial resistance. Shigellosis is one of the most improtant examples of this group of intestinal infections. In order to establish such parameters in Nagpur city, this study was carried out to determine the antimcrobial resistance profile of Shigella flexneri isolated from patients suffering from diahhrea admitted to Various hoapitals in Nagpur district, India. Materials and Methods: The study included 110 stool samples collected from patients during the 3 year period. All the isolates were characterized and confirmed by VITEK® 2 GN ID cards and antimicrobial susceptibility was tested by VITEK® 2 AST test cards. Results: We received 73 positive cultures of S. flexneri out of 110 stool samples during three year periods of January 2009 to January 2012. S. flexneri strains presented a high resistance rate to Ampicillin (100%), Chloramphenicol (76.71%), Trimethoprime-sulfamethaxazole (TMP-SMZ) (68.49%) and low resistance to third- and fourth-generation Cephalosporin. None of the isolates was found to be resistant to Ciprofloxacin (MIC ≥ 4), Norfloxacin (MIC ≥12), and Nalidixic acid (MIC ≥30). Conclusion: Our results provide data on antimicrobial resistance to choose a proper antibiotic for the treatment of Shigellosis in our country. According to current findings, Quinolones and Cephalosporins are the drug of choice for the diarrheic patients. In conclusion, systematic monitoring is needed to identify changes in the antimicrobial resistance.


Subject(s)
Adult , Anti-Bacterial Agents/therapeutic use , Cephalosporins/therapeutic use , Child, Preschool , Drug Resistance, Bacterial/drug effects , Dysentery/drug therapy , Dysentery/epidemiology , Dysentery/microbiology , Dysentery, Bacillary/drug therapy , Dysentery, Bacillary/epidemiology , Dysentery, Bacillary/microbiology , Feces/microbiology , Female , Humans , India/epidemiology , Infant , Infant, Newborn , Male , Medication Therapy Management/statistics & numerical data , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/statistics & numerical data , Microbiological Techniques/instrumentation , Microbiological Techniques/methods , Quinolones/therapeutic use , Shigella flexneri/drug effects , Shigella flexneri/isolation & purification
3.
Southeast Asian J Trop Med Public Health ; 2002 Dec; 33(4): 752-7
Article in English | IMSEAR | ID: sea-34152

ABSTRACT

Current data on pathogen prevalence and drug resistance patterns are important for treatment and vaccine-development strategies. An etiologic study of acute bacterial dysentery was conducted in children up to 12 years of age in 2 major hospitals in and around Bangkok. Stool samples or rectal swabs and clinical data were collected. Standard microbiological methods were used to detect Salmonella, Shigella, Campylobacter, Vibrio, Aeromonas and Plesiomonas. Pathogenic E. coli (ETEC, EIEC, STEC) was identified by digoxigenin-labeled probes. A total of 623 cases were enrolled: median age 11.0 months (range 1 month-12 years). At least one bacterial pathogen was isolated in 55% of cases. Campylobacter was the most common pathogen found (28%), whereas Salmonella, Shigella and ETEC were isolated from 18%, 9% and 6% respectively. EIEC, Vibrio and Plesiomonas were isolated from <1% and no STEC was detected. C. jejuni serotypes 36, 4 and 11 were the most common. The mean age of cases with Campylobacter was significantly lower than with Shigella (17.9 vs 52.8 months, p<0.001). Clinical presentations of Campylobacter and Shigella infections were compared: fever (28% vs 37%), abdominal colic (62% vs 80%, p<0.05), vomiting (38% vs 70%, p<0.001) and bloody stools (52% vs 48%). The Campylobacter isolates (80% C. jejuni, 20% C. coli) were 90% resistant to ciprofloxacin but sensitive to macrolides. All the Shigella isolates (70% S. sonnei) were sensitive to quinolones. Our study illustrates the increasing importance of quinolone-resistant Campylobacter and the decline of Shigella in the etiology of dysentery in Thailand. The clinical presentation of campylobacteriosis is similar to that of shigellosis, except that the patients may be younger and there may be less association with colic and vomiting; having fecal leukocytes will be >10/HPF. The use of macrolide antibiotics rather than quinolones would be reasonable in children <24 months of age; fluoroquinolones will be ineffective in at least half of culture-positive cases.


Subject(s)
4-Quinolones , Abdominal Pain/microbiology , Acute Disease , Age Distribution , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents , Campylobacter Infections/drug therapy , Child , Child, Preschool , Drug Resistance, Bacterial , Dysentery/drug therapy , Dysentery, Bacillary/drug therapy , Feces/cytology , Female , Fever/microbiology , Humans , Infant , Leukocyte Count , Macrolides , Male , Patient Selection , Population Surveillance , Prevalence , Salmonella Infections/drug therapy , Serotyping , Thailand/epidemiology , Vomiting/microbiology
4.
Bangladesh Med Res Counc Bull ; 1998 Aug; 24(2): 27-31
Article in English | IMSEAR | ID: sea-109

ABSTRACT

This was a community based, thirty cluster survey, carried out in Chittagong metropolitan area of Bangladesh, aimed to determine the extent of misuse of drugs in acute diarrhoea among under-five children. Data were collected from 360 mothers whose under-five children had suffered from acute diarrhoea during the preceding two weeks of interview. Data were pertained to type and duration of diarrhoea and treatment received. There were 339(94.2%) cases of acute watery diarrhoea and 21 (5.8%) cases of dysentery i.e. blood in stool. The mean duration of the diarrhoeal episode was 3.17 +/- 1.69 days (95% CI, 2.99-3.34). Three hundred twenty eight (91.1%) cases received treatment. There was a total of 401 consultations, out of which 328(81.8%) had first, 69(17.2%) had second and 4(1.0%) had third consultations. The first and second treatment were provided predominantly by care-providers (43.3%) and physicians (5.5%) respectively. Only 82(26.7%) cases of acute watery diarrhoea received WHO recommended treatment and only 5(23.8%) cases of dysentery received appropriate antibiotics. The rest 241(73.5%) cases received inappropriate treatment either antibiotic or drugs other than WHO recommendation. The average number of drugs prescribed per patient was 1.5 during the episode. The commonly prescribed drugs were metronidazole (38.6%) and antibiotics (17.3%). Those who consulted health professionals were at 5.7 times higher risk of receiving drugs. The mean duration of the episode of acute watery diarrhoea was increased significantly when drug is used in the treatment. It is concluded that there was high prevalence of misuse of drugs in the treatment of acute diarrhoea among under-five children which calls for intervention to improve the prescribing pattern as per WHO recommendation.


Subject(s)
Acute Disease , Analysis of Variance , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Antidiarrheals/therapeutic use , Bangladesh , Child, Preschool , Diarrhea/drug therapy , Dysentery/drug therapy , Fluid Therapy , Histamine H1 Antagonists/therapeutic use , Humans , Medication Errors , Metronidazole/therapeutic use , Prevalence , Rehydration Solutions/therapeutic use , Risk Factors , Time Factors , World Health Organization
5.
Bol. Hosp. San Juan de Dios ; 44(2): 121-2, mar.-abr. 1997. tab
Article in Spanish | LILACS | ID: lil-202601

ABSTRACT

El síndrome disentérico puede definirse com un cuadro diarreico bajo o colónico de evolución aguda o crónica, caracterizado por evacuaciones constituidas por materias fecales mezcladas con sangre y mucus. El curso puede ser febril o afebril. Generalmente existe dolor ano-rectal o localizado en los flancos y fosas ilíacas


Subject(s)
Clinical Laboratory Techniques , Dysentery/diagnosis , Dysentery/classification , Dysentery/drug therapy , Feces/parasitology
6.
Southeast Asian J Trop Med Public Health ; 1993 Mar; 24(1): 32-9
Article in English | IMSEAR | ID: sea-30558

ABSTRACT

The impact of an intervention program, measured by changes in the prescription of ORS, antibiotics and antidiarrheal drugs by those pharmacists and drugsellers after administering the proposed educational package was assessed. The results of the study indicated that, before the educational program started, ORS was prescribed by pharmacists for 31.4% and 15.7% of watery diarrhea and dysentery episodes, respectively. Only 18.9% and 13.3% of drugsellers gave ORS to assessors in case of watery diarrhea and dysentery. Antibiotics and antidiarrheal agents were prescribed extensively, watery and dysenteric diarrhea (84% and 56% for watery diarrhea by pharmacists and drugsellers; 92% and 60% for dysentery). Antidiarrheal drugs were used as frequently. After the educational program, the assessment of the prescription behavior of the pharmacists showed no change in ORS, antibiotics and antidiarrheal drugs prescribed to treat watery diarrhea. In dysentery, the effective percent change in prescribing ORS between pre- and post- intervention program was much higher in intervention group than the control group. For drugsellers, effective percent change in ORS usage in treatment of watery diarrhea was 11.8% compared with -7.7% in the control group. No such change was observed in treatment of dysentery. There was a slight significant change in behavior concerning use of antibiotics among subjects getting information by mail, compared to those who got full intervention, when the pre-intervention behavior, store type and treatment type was taken into account.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antidiarrheals/therapeutic use , Child, Preschool , Diarrhea/drug therapy , Dysentery/drug therapy , Education, Pharmacy , Humans , Pharmacists , Rehydration Solutions/therapeutic use , Thailand
SELECTION OF CITATIONS
SEARCH DETAIL